Authorized generics

Authorized Generics are prescription drugs produced by brand pharmaceutical companies and marketed under a private label, at generic prices. Authorized Generics compete with generic products in that they are identical to their brand counterpart in both active and inactive ingredients [ [http://www.ftc.gov/opa/2006/03/authgenerics.shtm FTC Proposes Study of Competitive Impacts of Authorized Generic Drugs ] ] ; whereas according to the Office of Generic Drugs, generic drugs must contain identical active ingredients as the brand [http://www.fda.gov/cder/ogd/#Introduction Office of Generic Drugs Home Page ] ] . Authorized Generics compete with generics on price, quality and availability in the generic marketplace, and are marketed to consumers during and after what is commonly known as “the 180-day exclusivity period”.

Headquartered in Cincinnati, OH, Prasco Laboratories has launched the largest number of Authorized Generic [http://www.authorizedgenerics.com/default.asp?contentid=4&
] products in the industry with multiple brand pharmaceutical partners.

Public Studies

According to Roper Public Affairs & Media, 2005 public research underlines consumer demand to have Authorized Generic prescription drugs availalble, showing over 80 percent of Americans want the option of Authorized Generic prescription drugs [ [http://goliath.ecnext.com/coms2/summary_0199-4629969_ITM Prasco Laboratories: Over 80 percent of Americans Want the Option of Authorized Generic Prescription Drugs; Research Underlines Consumer Demand to Have Authorized Generic Prescription Drugs Available. - Journal, Magazine, Article, Periodical ] ] . The FTC is currently undergoing a study entitled the "Competitive Implications of Authorized Generic Drugs" in the marketplace. Several independent organizations have commissioned their own studies including Pharmaceutical Research and Manufacturers of America [ [http://www.phrma.org/news_room/press_releases/new_study_finds_that_authorized_generics_can_lead_to_lower_drug_prices,_increased_savings/ PHRMA - New Study Finds That Authorized Generics Can Lead to Lower Drug Prices, Increased Savings ] ] , [http://www.phrma.org/files/IMS%20Authorized%20Generics%20Report_6-22-06.pdf] Sonecon [http://www.authorizedgenerics.com/default.asp?contentID=47] [ [http://www.sonecon.com/docs/studies/050207_authorizedgenerics.pdf Microsoft Word - The Impact of Auhtorized Generics - Shapiro-Hassett - May 2 2007.doc ] ] , GPhA [ [http://www.gphaonline.org/AM/Template.cfm?Section=Press_Releases&CONTENTID=2707&TEMPLATE=/CM/ContentDisplay.cfm GPhA | Independent Analysis Reveals that Authorized Generics are Bad for Consumers, Lead to Higher Pharmaceutical Prices ] ] [http://www.gphaonline.org/AM/Template.cfm?Section=Home&section=2006&template=/CM/ContentDisplay.cfm&ContentFileID=329] , furthering the competitive debate.

References